Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Fortress Biotech (FBIO) Long-Term Debt Issuances (2016 - 2024)

Historic Long-Term Debt Issuances for Fortress Biotech (FBIO) over the last 11 years, with Q4 2024 value amounting to -$33.7 million.

  • Fortress Biotech's Long-Term Debt Issuances fell 22042.14% to -$33.7 million in Q4 2024 from the same period last year, while for Sep 2024 it was $61.7 million, marking a year-over-year increase of 113436.0%. This contributed to the annual value of $28.0 million for FY2023, which is 46000.0% up from last year.
  • Latest data reveals that Fortress Biotech reported Long-Term Debt Issuances of -$33.7 million as of Q4 2024, which was down 22042.14% from $33.7 million recorded in Q3 2024.
  • Fortress Biotech's 5-year Long-Term Debt Issuances high stood at $42.1 million for Q1 2022, and its period low was -$42.1 million during Q2 2022.
  • For the 4-year period, Fortress Biotech's Long-Term Debt Issuances averaged around $4.4 million, with its median value being $7.0 million (2021).
  • As far as peak fluctuations go, Fortress Biotech's Long-Term Debt Issuances skyrocketed by 46000.0% in 2023, and later crashed by 22042.14% in 2024.
  • Over the past 4 years, Fortress Biotech's Long-Term Debt Issuances (Quarter) stood at $7.0 million in 2021, then fell by 28.57% to $5.0 million in 2022, then surged by 460.0% to $28.0 million in 2023, then tumbled by 220.42% to -$33.7 million in 2024.
  • Its last three reported values are -$33.7 million in Q4 2024, $33.7 million for Q3 2024, and $28.0 million during Q4 2023.